Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mor

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Israel Journal of Medical Sciences|March 1, 1997
The lower incidence of myotonic dystrophy in Ashkenazic Jews compared to North African Jews is associated with a significantly lower number of CTG trinucleotide repeatsR Mor-Cohen, N Magal, N Gadoth, et al.
American Heart Journal|July 1, 1985
Echocardiographic evaluation of patients with systemic sarcoidosisR F Lewin, R Mor, S Spitzer, et al.
Diabetes Care|October 7, 1997
Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjectsI Grosskopf, Y Ringel, G Charach, et al.
Journal of Thrombosis and Haemostasis : JTH|January 22, 2013
Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi JewsH Peretz, O Salomon, R Mor-Cohen, et al.
Environment International|October 12, 2015
Balancing the health benefits and environmental risks of pharmaceuticals: Diclofenac as an exampleV Acuña, A Ginebreda, J R Mor, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Bezafibrate therapy in patients with isolated low high-density lipoprotein cholesterol levels may have a beneficial effect in prevention of atherosclerosisM S Weintraub, I Grosskopf, G Charach, et al.
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
ADP-coupled integrin regulation by the extracellular redox systemJ Lahav, O Hess, D Calo, et al.
Postgraduate Medical Journal|June 1, 1986
Pneumonectomy in pulmonary mucormycosis complicating Behçet's diseaseM Santo, A Levy, M J Levy, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombastheniaN Rosenberg, H Hauschner, H Peretz, et al.
Clinical Genetics|January 11, 2014
Founder mutation for Huntington disease in Caucasus JewsO Melamed, D M Behar, C Bram, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Israel Journal of Medical Sciences|March 1, 1997
The lower incidence of myotonic dystrophy in Ashkenazic Jews compared to North African Jews is associated with a significantly lower number of CTG trinucleotide repeatsR Mor-Cohen, N Magal, N Gadoth, et al.
American Heart Journal|July 1, 1985
Echocardiographic evaluation of patients with systemic sarcoidosisR F Lewin, R Mor, S Spitzer, et al.
Diabetes Care|October 7, 1997
Metformin enhances clearance of chylomicrons and chylomicron remnants in nondiabetic mildly overweight glucose-intolerant subjectsI Grosskopf, Y Ringel, G Charach, et al.
Journal of Thrombosis and Haemostasis : JTH|January 22, 2013
Type I mutation in the F11 gene is a third ancestral mutation which causes factor XI deficiency in Ashkenazi JewsH Peretz, O Salomon, R Mor-Cohen, et al.
Environment International|October 12, 2015
Balancing the health benefits and environmental risks of pharmaceuticals: Diclofenac as an exampleV Acuña, A Ginebreda, J R Mor, et al.
Metabolism: Clinical and Experimental|November 1, 1995
Bezafibrate therapy in patients with isolated low high-density lipoprotein cholesterol levels may have a beneficial effect in prevention of atherosclerosisM S Weintraub, I Grosskopf, G Charach, et al.
Pathophysiology of Haemostasis and Thrombosis|July 21, 2006
ADP-coupled integrin regulation by the extracellular redox systemJ Lahav, O Hess, D Calo, et al.
Postgraduate Medical Journal|June 1, 1986
Pneumonectomy in pulmonary mucormycosis complicating Behçet's diseaseM Santo, A Levy, M J Levy, et al.
Journal of Thrombosis and Haemostasis : JTH|December 20, 2005
A 13-bp deletion in alpha(IIb) gene is a founder mutation that predominates in Palestinian-Arab patients with Glanzmann thrombastheniaN Rosenberg, H Hauschner, H Peretz, et al.
Clinical Genetics|January 11, 2014
Founder mutation for Huntington disease in Caucasus JewsO Melamed, D M Behar, C Bram, et al.
Pageof 3